U
Aktis Oncology, Inc. AKTS
$18.75 $0.030.16% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 12/31/2024
Total Cash And Short-Term Investments 226.79M 297.17M
Total Receivables 1.10M 1.10M
Inventory -- --
Prepaid Expenses 2.42M 2.59M
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets 230.31M 300.85M

Total Current Assets 230.31M 300.85M
Net Property, Plant & Equipment 27.25M 20.87M
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 7.33M 4.46M
Total Assets 264.89M 326.18M

Total Accounts Payable 1.74M 1.92M
Total Accrued Expenses 9.52M 6.33M
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current 1.32M 1.30M
Total Finance Division Other Current Liabilities 18.66M 9.28M
Total Other Current Liabilities 18.66M 9.28M
Total Current Liabilities 31.24M 18.82M

Total Current Liabilities 31.24M 18.82M
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases 10.23M 10.71M
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 36.16M 51.04M
Total Liabilities 77.63M 80.58M

Common Stock & APIC 10.37M 4.91M
Retained Earnings -156.56M -92.83M
Treasury Stock & Other 42.00K 124.00K
Total Common Equity -146.15M -87.80M

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible 333.41M 333.41M
Preferred Stock, Others -- --
Total Preferred Equity 333.41M 333.41M

Total Common Equity -146.15M -87.80M
Total Preferred Equity 333.41M 333.41M
Total Minority Interest -- --
Total Equity 187.26M 245.61M